WHO Recommends GLP-1 Drugs as Effective Treatment for Obesity In a significant development within global health policy, the World Health Organization (WHO) has officially recommended glucagon-like peptide-1 (GLP-1) receptor agonist drugs as a treatment option for obesity. This move marks a strategic shift in addressing…